The Purpose of this study was to investigate the possibility of using [C-11]thymidine as a tumor marker for positron emission tomography studies. Biodistribution studies were set up to investigate the in vivo behavior of [C-11]thymidine. Simultaneously, the DNA incorporation in fast dividing tissues and catabolism was studied. Our results confirm that [C-11]thymidine can be used for detection of cell proliferation by positron emission tomography. As such, it can produce supplementary information in cancer research
The introduction of the use of labelled DNA precursors into cell proliferation research has resulted...
This study evaluated the ability of 14C-Thymidine for detecting the early effects of irradiation on ...
FDG, the most common radiopharmaceutical for PET imaging in oncology, is not tumor-specific. Signifi...
The Purpose of this study was to investigate the possibility of using [C-11]thymidine as a tumor mar...
Increased cellular proliferation is an integral part of the cancer phenotype. Several in vitro assay...
The relative utilization of endogenously synthesized thymidine nucleotides and exogenously supplied ...
Noninvasive measurement of liver regeneration with positron emission tomography has been attempted w...
Background: Some anticancer drugs inhibit thymidylate syn-thase (TS), a key enzyme for thymidine nuc...
Purpose: In order to obtain a thymidine analog that might prove simpler to use for imaging DNA synth...
A standardized in vitro system for the measurement of 3H-thymidine incorporation into tissue explant...
quantitative approach for studying nucleoside uptake in cells on the condition the fraction of [meth...
The thymidine analog 18F-3-deoxy-3-fluorothymidine (FLT) is being used clinically for PET imaging of...
4'-[methyl-C-11]thiothymidine (C-11-4DST) is a novel radiopharmaceutical that can be used for tumor ...
2-[11C]Thymidine (TdR), a PET tracer for cellular proliferation, may be advantageous for monitoring ...
4'-[methyl-C-11]thiothymidine (C-11-4DST) is a novel radiopharmaceutical that can be used for tumor ...
The introduction of the use of labelled DNA precursors into cell proliferation research has resulted...
This study evaluated the ability of 14C-Thymidine for detecting the early effects of irradiation on ...
FDG, the most common radiopharmaceutical for PET imaging in oncology, is not tumor-specific. Signifi...
The Purpose of this study was to investigate the possibility of using [C-11]thymidine as a tumor mar...
Increased cellular proliferation is an integral part of the cancer phenotype. Several in vitro assay...
The relative utilization of endogenously synthesized thymidine nucleotides and exogenously supplied ...
Noninvasive measurement of liver regeneration with positron emission tomography has been attempted w...
Background: Some anticancer drugs inhibit thymidylate syn-thase (TS), a key enzyme for thymidine nuc...
Purpose: In order to obtain a thymidine analog that might prove simpler to use for imaging DNA synth...
A standardized in vitro system for the measurement of 3H-thymidine incorporation into tissue explant...
quantitative approach for studying nucleoside uptake in cells on the condition the fraction of [meth...
The thymidine analog 18F-3-deoxy-3-fluorothymidine (FLT) is being used clinically for PET imaging of...
4'-[methyl-C-11]thiothymidine (C-11-4DST) is a novel radiopharmaceutical that can be used for tumor ...
2-[11C]Thymidine (TdR), a PET tracer for cellular proliferation, may be advantageous for monitoring ...
4'-[methyl-C-11]thiothymidine (C-11-4DST) is a novel radiopharmaceutical that can be used for tumor ...
The introduction of the use of labelled DNA precursors into cell proliferation research has resulted...
This study evaluated the ability of 14C-Thymidine for detecting the early effects of irradiation on ...
FDG, the most common radiopharmaceutical for PET imaging in oncology, is not tumor-specific. Signifi...